Jefferies, Kempen & Co and Gilbert Dupont Private Placement of 25.1 million Euros of Nanobiotix
Baker McKenzie advised Jefferies, Kempen & Co and Gilbert Dupont in the context of a private placement with a total amount of 25.1 million euros carried out by Nanobiotix, a nanomedicine company developing new approaches to the local treatment of cancer. The new shares, representing 9.99% of the outstanding Company shares prior to the offering, have been issued primarily with qualified institutional investors, the majority of which from the United States and Europe. The settlement took place on April 11, 2017.